Category: Pharmaceuticals
Global Pharmaceuticals
-
Global Biosimilars Market – Products, Applications and Regulations
... such as yeast, bacteria, or animal cells and are complex and sensitive to changes in manufacturing, in contrast to generic drugs, which are precise chemical replicas of small-molecule drugs. Biosimilars include various types of products, ... Read More
-
Global Immunotherapy Drugs Market (2025 Edition): Analysis By Indication (Cancer, Autoimmune & Inflammatory Diseases, Other Indications), By Drug Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... & Inflammatory Diseases, Other Indications), By Drug Type (Monoclonal Antibodies, Immunomodulators, Vaccines) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030. The report analyses the Immunotherapy Drugs Market ... Read More
-
Biopharmaceuticals – A Global Market Overview
... complex molecules, including proteins, nucleic acids, and vaccines, in contrast to traditional small-molecule drugs. Biopharmaceutical products are developed to address chronic, complex, and rare illnesses, providing targeted treatments that conventional drugs often lack. They are ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine Indication, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Animal Feed Additives
... at a CAGR of 5.4% over the analysis period 2024-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$20.7 Billion by the end of ... Read More
-
Medicated Skin Care Products
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.9 Billion by the ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Disabled and Elderly Assistive Technology
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Communication Aids, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$16.3 Billion ... Read More
-
Algae Omega 3 Ingredients
... 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. EPA / DHA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.0 Billion by ... Read More
-
Gas Masks
... CAGR of 7.0% over the analysis period 2024-2030. Disposable Respirators, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.8 Billion by the end of the analysis ... Read More
-
Pharmacy Repackaging Systems
... at a CAGR of 7.3% over the analysis period 2024-2030. Blister Card/Compliance Packaging Systems, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.0 Billion by the ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Disposable Masks
... CAGR of 6.2% over the analysis period 2024-2030. Surgical Masks, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$19.1 Billion by the end of the analysis ... Read More
-
Radio Frequency Identification (RFID) Technology
... Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$51.8 Billion ... Read More
-
Drug Discovery Technologies
... at a CAGR of 8.7% over the analysis period 2024-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$92.7 Billion by the end ... Read More
-
Analgesics
... 5.3% over the analysis period 2024-2030. Prescription Analgesics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$43.8 Billion by the end of the analysis period. Growth ... Read More
-
Ablation Technologies
... CAGR of 9.7% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$3.7 Billion by the end of the analysis ... Read More
-
Allergy Diagnostics
... CAGR of 10.0% over the analysis period 2024-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$4.5 Billion by the end of ... Read More
-
Corporate Wellness
... CAGR of 6.5% over the analysis period 2024-2030. Health Risk Assessment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$27.9 Billion by the end of the ... Read More
-
Integrated Workplace Management Systems (IWMS)
... Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2024-2030. IWMS Solutions, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$5.5 Billion ... Read More
-
Pharmaceutical Packaging
... CAGR of 8.2% over the analysis period 2024-2030. Plastics & Polymers Material, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$114.0 Billion by the end of ... Read More
-
Cycling Power Meters
... at a CAGR of 4.4% over the analysis period 2024-2030. Crank Arm-Based Power Meters, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$197.5 Million by the ... Read More
-
Sex Toys
... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More
Research Assistance
